Fertility

Pozitivf Secures $20M in Funding to Democratize Fertility Treatment for All

San Antonio-based fertility clinic network Pozitivf has recently raised $20 million in a funding round led by MonCap. This investment, among the most significant in the fertility space, is aimed at expanding Pozitivf’s reach and making fertility treatments such as IVF more affordable across the United States. Pozitivf’s service model offers IVF procedures starting at a cost of $7,995, which is significantly…

Proov Launches Comprehensive At-Home Fertility Program as Affordable IVF Alternative

Reproductive health company Proov has recently launched the Proov Path to Pregnancy, a new at-home fertility treatment program offering a less invasive and more affordable option compared to traditional in-vitro fertilization (IVF). Amy Beckley, CEO and Founder of Proov, was inspired to create this program based on her personal challenges with infertility, aiming to provide easier access to effective fertility solutions. “In…

Inherent Biosciences and Genomic Prediction Partner to Advance Male Reproductive Health

Inherent Biosciences and Genomic Prediction have announced a new commercial partnership to integrate Inherent Biosciences’ Epigenetic Sperm Quality Test (SpermQT), into Genomic Prediction’s clinical laboratory tests, focusing on male reproductive health. For a long time, the narrative around infertility has primarily focused on women, with limited progress in providing men with actionable insights into their fertility. The SpermQT test, developed by Inherent…

Fertilitywise Introduces Membership Program for Fertility Support

Fertilitywise has launched an online membership program designed to provide resources and a community for individuals and couples dealing with fertility issues. The program aims to offer educational articles and moderated discussion boards to support those undergoing fertility treatments. The platform addresses the need for clear information about fertility processes and treatments. It includes articles on various aspects of fertility, written in…

Singapore-based Zora Health Raises $740K to Launch Integrated Fertility Care Platform

Singapore-based Zora Health has announced the launch of its integrated fertility care and financing platform, backed by $740K in funding. This investment round saw participation from notable angel investors, including Cheryl Goh (Founding CMO of Grab), Prajit Nanu (CEO of Nium), Alan Jiang (CEO of Beam), and Lisa Enckell (Venture Partner, Antler), as well as Asa Liden (former COO of Pitch.com). Venture…

Fertilis’ MicroICSI Is Set to Enhance IVF Outcomes According to New Study

Fertilis, an Australian medtech company, has developed the prototype of an innovative device, microICSI, aimed at refining the IVF process. A recent study published in the Journal of Assisted Reproduction and Genetics study, titled “A micro-fabricated device (microICSI) improves porcine blastocyst development and procedural efficiency for both porcine intracytoplasmic sperm injection and human microinjection,” now underscores the device’s effectiveness in improving embryo…

Pharma Company IBSA Acquires Aura Fertility to Bolster IVF Patient Support

IBSA, a pharma company actively involved in reproductive health, has acquired Aura Fertility, an app with the goal of improving the IVF experience. This move is in line with IBSA’s goal to improve patient experiences and outcomes in fertility by focusing on the emotional aspects and challenges associated with IVF. London-based Aura Fertility was established in 2020 by Abi Hannah, Karen Hanson,…

Granata Bio Raises $14M in Series A Funding to Enhance Fertility Treatment Options

Granata Bio, a biopharma company specializing in fertility medications, has announced the closure of a $14 million Series A funding round. Led by GV (Google Ventures), this funding round includes significant contributions from CooperSurgical, Gedeon Richter, Alumni Ventures, Amboy Street Ventures, Vibe Bio, and others. The investment aims to accelerate the development of Granata Bio’s fertility biopharma pipeline, addressing a critical gap…